Ethereum is trading around the $2,150 level as volatility persists across the broader cryptocurrency market, reflecting a phase of uncertainty following recent price swings. While the asset has managed to stabilize near current levels, momentum remains fluctu…

— First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfunction –

Ethereum is trading above the $2,150 level after pulling back from recent highs near $2,380 reached earlier this week, reflecting a cooling phase following a short-term surge in bullish momentum. The retrace suggests that while buyers were able to push prices…

Akusoli Fat Burner Metabolism Bundle ingredient dosages, proprietary blend labeling, magnetic acupressure insole claims, and policy terms outlined….

GaraHerb ingredient claims, proprietary blend dosing, scientific references, refund terms, and consumer considerations compiled for 2026….

Akemi Detox Tea claims evaluated: how 12 botanical ingredients are positioned for fat burning, bloating relief, and energy support in 2026….

ReflexMD GLP-1 report covers compounded semaglutide & tirzepatide pricing, telehealth process, safety considerations, and platform verification….

Retina Clear 2026 report: “Red Root Hack” claims, ingredient research vs. marketing, proprietary blend analysis, pricing, and refund terms….

MONTREAL and CHARLOTTE, N.C., March 20, 2026 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial resu…

Bitcoin price may face an uphill battle to reclaim its range highs, but historical data suggests bulls have a good chance.

REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results U.S. Commercialization Off to a Strong Start in…

DEER PARK, Ill., March 19, 2026 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial resul…

Here's how the broker viewed the company's quarterly update. The post Bell Potter is tipping this ASX small-cap to double in the next year appeared first on The Motley Fool Australia.

US FDA has approved Wegovy® HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess body weight and maintain weight reduction long-term. …

GameStop Corp. shares traded modestly lower in early trading on March 19, 2026, as investors positioned themselves for the retailer's upcoming quarterly earnings report later this month.